Announced Fri, 24 Jul · 12:17 IST
Board meeting on Aug 11 to consider Q1 FY26 results
Results View source PDF
NEPHROPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹675.95
prior close
₹675.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.1+0.2+0.3+1.0—————————
Up moveDown movePending
AI summary
Nephrocare Health Services (NephroPlus) has scheduled a board meeting on August 11, 2026 to consider and approve the unaudited standalone and consolidated financial results for Q1 FY26-27 (quarter ended June 30, 2026). The trading window for designated persons and their immediate relatives has been closed from June 22 to August 13, 2026.
Likely market impact
Routine intimation. Watch for Q1 results on Aug 11 - earnings could move the stock.